Sunesis Pharmaceuticals (SNSS) Posts Q4 Loss of 20c/Share
Tweet Send to a Friend
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.20), $0.01 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
